Clinical Trial Update: Preoperative Radiotherapy/ Oxaliplatin/ Capecitabine Treatment For Unresectable Locally-advanced Rectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating preoperative radiotherapy with oxaliplatin and capecitabine for unresectable locally advanced rectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: Sanofi | Conditions: Rectal Neoplasms | Phase 2 | Status: COMPLETED